Psilocybin for Treatment-Resistant Depression - Dr. Robin Carhart-Harris
Dr. Robin Carhart-Harris speaks about the use of psilocybin for treatment-resistant depression. Here are some key points from this interview: - Psilocybin, a psychedelic, is a 5-HT2A agonist. Stimulation of the 5-HT2A receptor promotes neural plasticity -A potential mechanism of action of psilocybin in treatment-resistant depression involves “brain resetting” - Psilocybin has a good safety profile. However, patients may experience challenging psychological experiences that may turn out to be frightening for some people - Administration of psychedelics needs to be done in a controlled environment with psychological support Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
